Loss of the chromatin remodeler, <i>ATRX</i> , promotes aggressive features of osteosarcoma with increased NF-κB signaling and integrin receptor binding

Suzanne Bartholf DeWitt(Duke Medical Center), William C. Eward(Duke Medical Center)
bioRxiv (Cold Spring Harbor Laboratory)
April 25, 2022
Cited by 1


Related Papers